Evidence map›Paper›PMID 15592731›Full record

Trial reportJournal of neurology2004

EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.

M Saletu, P Anderer, G M Saletu-Zyhlarz, M Mandl, O Arnold, J Zeitlhofer, B Saletu

Abstract readClinical TrialComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of neurology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Pooled it
  2. Guideline
  3. Trial
  4. Modafinil effects on middle-frequency oscillatory power during rule selection in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  11. Electroencephalographic rhythms in Alzheimer's disease.International journal of Alzheimer's disease · 2011
    Article
  12. Review
  13. Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2008
    Article
  14. Review
  15. Mechanisms of modafinil: A review of current research.Neuropsychiatric disease and treatment · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M SaletuDepartment of Neurology, School of Medicine, University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. michael.saletu@meduniwien.ac.at
P Anderer
G M Saletu-Zyhlarz
M Mandl
O Arnold
J Zeitlhofer
B Saletu
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to identify brain regions associated with vigilance in untreated and modafinil-treated narcoleptic patients by means of low-resolution brain electromagnetic tomography (LORETA). 16 drug-free narcoleptics and 16 normal controls were included in the baseline investigation. Subsequently patients participated in a double-blind, placebo-controlled crossover study receiving a three-week fixed titration of modafinil (200, 300, 400 mg) and placebo. Measurements comprised LORETA, the Multiple Sleep Latency Test (MSLT) and the Epworth Sleepiness Scale (ESS) obtained before and after three weeks' therapy. Statistical overall analysis by means of the omnibus significance test demonstrated significant inter-group differences in the resting (R-EEG), but not in the vigilance-controlled recordings (V-EEG). Subsequent univariate analysis revealed a decrease in alpha-2 and beta 1-3 power in prefrontal, temporal and parietal cortices, with the right hemisphere slightly more involved in this vigilance decrement. Modafinil 400 mg/d as compared with placebo induced changes opposite to the aforementioned baseline differences (key-lock principle) with a preponderance in the left hemisphere. This increase in vigilance resulted in an improvement in the MSLT and the ESS. LORETA provided evidence of a functional deterioration of the fronto-temporo-parietal network of the right-hemispheric vigilance system in narcolepsy and a therapeutic effect of modafinil on the left hemisphere, which is less affected by the disease.

Indexed as

AdultArousalBenzhydryl CompoundsBrain MappingDouble-Blind MethodDrug Administration ScheduleElectroencephalographyElectromagnetic PhenomenaFemaleFunctional LateralityHumansMagnetic Resonance ImagingMaleMiddle AgedModafinilNarcolepsyBenzhydryl CompoundsModafinilNeuroprotective AgentsPlacebos

Identifiers

PMID15592731
OpenAlexW2045595436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.